1. Home
  2. SOHO vs EVAX Comparison

SOHO vs EVAX Comparison

Compare SOHO & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sotherly Hotels Inc.

SOHO

Sotherly Hotels Inc.

HOLD

Current Price

$2.16

Market Cap

43.8M

Sector

Real Estate

ML Signal

HOLD

EVAX

Evaxion Biotech

HOLD

Current Price

$5.08

Market Cap

42.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOHO
EVAX
Founded
2004
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
42.7M
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
SOHO
EVAX
Price
$2.16
$5.08
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$12.33
AVG Volume (30 Days)
93.7K
89.1K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$177,571,118.00
$7,650,000.00
Revenue This Year
$13.93
$128.77
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
132.17
52 Week Low
$0.59
$1.20
52 Week High
$2.20
$12.15

Technical Indicators

Market Signals
Indicator
SOHO
EVAX
Relative Strength Index (RSI) 55.58 46.96
Support Level $2.16 $4.56
Resistance Level $2.20 $5.48
Average True Range (ATR) 0.02 0.43
MACD -0.01 0.02
Stochastic Oscillator 50.00 43.00

Price Performance

Historical Comparison
SOHO
EVAX

About SOHO Sotherly Hotels Inc.

Sotherly Hotels Inc is engaged in Hotel operations. The company is a self-managed and self-administered lodging real estate investment trust that was formed to own, acquire, renovate, and reposition full-service, upscale, and upper-upscale hotel properties located in primary markets in the mid-Atlantic and southern United States. It generates revenue through the rooms, food, beverage, and other services. Geographically, the group has its presence in the regions of Florida, Georgia, Indiana, Maryland, North Carolina, Pennsylvania, Texas, and Virginia.

About EVAX Evaxion Biotech

Evaxion AS is a techBio company based on its AI platform, AI-Immunology. Evaxion's proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing innovative and targeted treatment options.

Share on Social Networks: